What Happened?
Seattle, WA-based Bardy Diagnostics Appointed Ed Vertatschitsch as Chief Operating Officer
About the Company
Bardy Diagnostics, Inc. (bardydx.com) has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM™) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM™ can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. Developed on the principle that non-invasive cardiac monitoring should provide an excellent quality atrial signal, the CAM is designed to be placed along the sternum—over the heart— to optimize P-wave signal capture. The result is improved ECG resolution, providing more information about the heart rhythm which may lead to more clinically actionable diagnoses.
About the Person
Ed Vertatschitsch is Chief Operating Officer at Bardy Diagnostics. Previously, Ed held various senior IT leadership roles in the industry.
Info Source
News
Short Profile